Projects funded by the NCN
Effect of modulation of the GPR39 zinc receptor on glutamatergic and gabaergic transmission in the context of antidepressant and anxiolytic activity.
2016/21/N/NZ7/03094
Keywords:
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 11 - announced on 2016-03-15
Amount awarded: 100 000 PLN
Project start date (Y-m-d): 2017-03-08
Project end date (Y-m-d): 2019-09-07
Project duration:: 30 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- Komputer typu laptop (3 000 PLN)
- Uniesiony labirynt krzyżowy (7 000 PLN)
Information in the final report
- Publication in academic press/journals (1)
- The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmissionAuthors:Gabriela Starowicz; Dominika Siodłak; Gabriel Nowak; Katarzyna MlyniecAcademic press:Pharmacological Reports (rok: 2023, tom: Online ahead of print, strony: Online ahead of print), Wydawca: SpringerStatus:PublishedDOI:10.1007/s43440-023-00478-0 - link to the publication